IL-33 Protects Mice against DSS-Induced Chronic Colitis by Increasing Both Regulatory B Cell and Regulatory T Cell Responses as Well as Decreasing Th17 Cell Response

Figure 3

Cytokine production by lymphocytes isolated from the MLN of IL-33- and PBS-treated mice with DSS-induced colitis. (a) MLN cells with or without anti-CD3 and anti-CD28 mAb (CD3/CD28) stimulations. (b) MLN cells without any stimulation. Data indicate mean ± SD of each group () obtained from a representative of three independent experiments and were valued by a Student -test (, , or ).

(a)

(b)